Purchase Order 75N94024P00615
Award Date 8/20/24
Potential Completion Date 8/19/25
Potential Value $10K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Kent, WA 98032, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- This federal contract award was granted to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies, by the Department of Health and Human Services (HHS). The contract, worth $24,908.80, is a firm fixed-price purchase order for the company to provide a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies, including the...
- The U.S. Department of Health and Human Services (HHS) awarded a firm fixed-price Purchase Order contract worth $24,454.50 to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies. This contract, awarded on August 21, 2014, is not set aside for small businesses. Stemcell Technologies Inc. primarily...
- This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...
- Stemcell Technologies Inc., a Canadian biotechnology company, was awarded a $7,485 firm-fixed-price purchase order contract (HHSN272201100756P) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, which does not have a small business set-aside, was awarded on August 10, 2011 with a completion date of July 30, 2012. Stemcell Technologies Inc. primarily...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract to Stemcell Technologies Inc., a Canadian biotechnology company, for the provision of laboratory equipment and supplies. The contract has a ceiling value of $47,405.00 and runs through November 25, 2009. It was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Stemcell Technologies...
- Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
- This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...
- This is a $18,772.80 firm fixed-price purchase order awarded to Stemcell Technologies Inc. by the National Institutes of Health (NIH) Clinical Center on November 13, 2024. Stemcell Technologies Inc. is a subsidiary of the Canadian biotechnology company Stemcell Technologies. This contract is not set aside for small businesses. The award provides specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives...
- This federal contract award, valued at $4,356.00, was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The contract is a Firm Fixed Price Purchase Order that runs through October 18, 2024. Stemcell Technologies Inc. is not a small business set-aside, but the company has been awarded some small business set-aside contracts in the past, indicating flexibility in its contracting status. Stemcell Technologies...